patient-derived head and neck cancer organoids
patient-derived head and neck cancer organoids
- 64 samples
- DAC: EGAC00001000432
- Technology: Illumina NovaSeq 6000
DUO:0000007 version: 2021-02-23
disease specific research
This data use permission indicates that use is allowed provided it is related to the specified disease.
ModifiersMONDO:0004992
DUO:0000019 version: 2021-02-23
publication required
This data use modifier indicates that requestor agrees to make results of studies using the data available to the larger scientific community.
DUO:0000021 version: 2021-02-23
ethics approval required
This data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval.
Policy for study "Treatment stratification and biomarker validation using patient-derived head and neck cancer organoids".
DUO0000007; MONDO:0004992 (only for purposes that are related to the specific disease, namely Cancer) DUO0000019 (=only if the requestor agrees to make the results, of the studies using these data, available to the larger scientific community) DUO0000021 (=only if the requestor provides documentation regarding the approval of the local IRB/ERB for the study these data will be used for) For details please contact dacdbg@umcutrecht.nl
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001007076 | Other |